CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatment

Schizophr Res. 1991 Dec;6(1):15-23. doi: 10.1016/0920-9964(91)90016-k.

Abstract

A topographic CEEG investigation was carried out in 20 drug-free, DSM-IIIR diagnosed schizophrenics and in a group of matched healthy controls. The effects of acute and chronic haloperidol treatment were then assessed in the patient group. On the baseline recording, schizophrenics showed a widespread increase in delta, theta 1 and beta 3 amplitude. Acute haloperidol administration produced a decrease in delta and an increase in slow beta amplitude. After 28 days of treatment, delta and fast beta were reduced while theta 2 and alpha 1 were increased. CEEG abnormalities in schizophrenic subjects appear, therefore, to be reduced by chronic neuroleptic treatment.

MeSH terms

  • Adult
  • Brain Mapping / instrumentation
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / physiopathology*
  • Chronic Disease
  • Dose-Response Relationship, Drug
  • Electroencephalography / drug effects*
  • Electroencephalography / instrumentation
  • Evoked Potentials / drug effects
  • Female
  • Haloperidol / therapeutic use*
  • Humans
  • Male
  • Schizophrenia / drug therapy*
  • Schizophrenia / physiopathology*
  • Schizophrenic Psychology*
  • Signal Processing, Computer-Assisted / instrumentation

Substances

  • Haloperidol